Changeflow GovPing Healthcare GEM Premier 5000 Class II Device Recall Z-1539-...
Urgent Enforcement Amended Final

GEM Premier 5000 Class II Device Recall Z-1539-2026

Favicon for changeflow.com FDA: Device Recalls Class II
Filed March 18th, 2026
Detected March 29th, 2026
Email

Summary

The FDA has issued a Class II device recall (Z-1539-2026) for the GEM Premier 5000, Model No. 00055430010, due to an increased incidence of 'Process Control Solution Not Detected' errors. This recall affects worldwide distribution, including the US.

What changed

The FDA has initiated a Class II device recall (Z-1539-2026) for the GEM Premier 5000, Model No. 00055430010, manufactured by Instrumentation Laboratory. The recall is prompted by confirmed customer complaints indicating an increased incidence of 'Process Control Solution Not Detected' (PCSND) errors during warm-up, which can lead to GEM PAK ejection and require re-insertion. The device has been distributed worldwide, including nationwide in the US and in several other countries.

Healthcare providers and facilities using the GEM Premier 5000 should be aware of this recall and the potential for PCSND errors. While the document does not specify immediate actions beyond acknowledging the ongoing recall, users should monitor communications from Instrumentation Laboratory and the FDA regarding any corrective actions or updated guidance. Non-compliance with recall procedures or continued use of a malfunctioning device could pose risks to patient care and diagnostic accuracy.

What to do next

  1. Review FDA recall notice Z-1539-2026 for GEM Premier 5000
  2. Monitor communications from Instrumentation Laboratory regarding corrective actions
  3. Assess potential impact of PCSND errors on patient care and diagnostic accuracy

Source document (simplified)

Instrumentation Laboratory

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1539-2026 · 20260318 · Ongoing

Product

GEM Premier 5000; Model No. 00055430010.

Reason for Recall

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...

Distribution

Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 18th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1539-2026

Who this affects

Applies to
Drug manufacturers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Device Recalls
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Compliance
Topics
Product Safety Recall Management

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.